InSilico Medicine (HKG:3696) Chairman and CEO Aleksandrs Zavoronkovs has increased his stake in the company by purchasing an additional 113,500 shares, according to a Monday bourse filing.
The biotech company said Zavoronkovs purchased the shares on the open market between Sept. 4 and Sept. 7 using personal funds.
Following the purchase, Zavoronkovs now owns 46,757,000 shares, or about 8.02% of outstanding shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.